- Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study. Loghin, M.E., Prados, M.D., Wen, P., Junck, L., Lieberman, F., Fine, H., Fink, K.L., Metha, M., Kuhn, J., Lamborn, K., Chang, S.M., Cloughesy, T., DeAngelis, L.M., Robins, I.H., Aldape, K.D., Yung, W.K. Clin. Cancer Res. (2007)